US20110196039A9
(en)
*
|
1994-10-05 |
2011-08-11 |
Kaesemeyer Wayne H |
Controlled release arginine formulations
|
ATE261935T1
(de)
*
|
1997-12-08 |
2004-04-15 |
Bristol Myers Squibb Co |
Neue metformin salze und verfahren
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US20030153607A1
(en)
*
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
US20040081697A1
(en)
*
|
1998-11-12 |
2004-04-29 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
JP2003514011A
(ja)
*
|
1999-11-16 |
2003-04-15 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
|
MY125516A
(en)
|
1999-11-16 |
2006-08-30 |
Smithkline Beecham Plc |
Novel composition based on thiazolidinedione and metformin and use
|
JP2003521507A
(ja)
*
|
2000-02-04 |
2003-07-15 |
ディポメド,インコーポレイティド |
ゼロ次薬物放出に接近するシェル−コア剤形
|
US6955821B2
(en)
*
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US7838032B2
(en)
*
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US7985420B2
(en)
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
FR2811571B1
(fr)
*
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
WO2002012177A1
(en)
*
|
2000-08-03 |
2002-02-14 |
Igor Anatolievich Pomytkin |
Composition of metformin with succinic acid or salts thereof and method for treating diabetes
|
US6531158B1
(en)
*
|
2000-08-09 |
2003-03-11 |
Impax Laboratories, Inc. |
Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
|
WO2002028181A1
(en)
*
|
2000-10-02 |
2002-04-11 |
Usv Limited |
Sustained release pharmaceutical compositions containing metformin and method of its production
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
EP1723948A1
(en)
|
2000-11-03 |
2006-11-22 |
Andrx Labs, LLC |
Controlled release compositions of biguanide with less side effects and treatment regimen thereof
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
FR2816840B1
(fr)
|
2000-11-17 |
2004-04-09 |
Flamel Tech Sa |
Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
|
FR2818906B1
(fr)
*
|
2000-12-29 |
2004-04-02 |
Dospharma |
Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
|
CA2434169C
(en)
*
|
2001-01-12 |
2011-03-15 |
Sun Pharmaceutical Industries Limited |
Spaced drug delivery system
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
EP1377276B1
(en)
*
|
2001-04-10 |
2011-10-05 |
Sun Pharma Advanced Research Company Limited |
Timed pulse release composition
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
CA2445086C
(en)
|
2001-05-01 |
2008-04-08 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
FR2825023B1
(fr)
|
2001-05-23 |
2005-04-15 |
Flamel Tech Sa |
Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
|
US6524618B1
(en)
|
2001-06-12 |
2003-02-25 |
Vijai Kumar |
Directly compressible extended-release matrix formulation for metformin hydrochloride
|
WO2003004009A1
(en)
*
|
2001-07-02 |
2003-01-16 |
Geneva Pharmaceuticals, Inc. |
Pharmaceutical composition
|
ES2398348T3
(es)
|
2001-07-04 |
2013-03-15 |
Sun Pharma Advanced Research Company Ltd |
Sistema de administración de fármacos controlada por retención gástrica
|
JP2005525299A
(ja)
*
|
2001-09-14 |
2005-08-25 |
スコラー インコーポレイテッド |
アミノ酸調節性の長期放出投薬形態
|
IN192180B
(zh)
*
|
2001-09-28 |
2004-03-06 |
Ranbaxy Lab |
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
HUP0402058A3
(en)
*
|
2001-11-06 |
2006-04-28 |
Ranbaxy Lab Ltd |
Controlled release tablets of metformin and process for their preparation
|
IL146462A
(en)
|
2001-11-13 |
2015-02-26 |
Lycored Bio Ltd |
Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
|
ITFI20010230A1
(it)
*
|
2001-11-29 |
2003-05-29 |
Menarini Int Operations Lu Sa |
Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
|
CN101410091A
(zh)
*
|
2002-01-04 |
2009-04-15 |
Ivax研究公司 |
用于持续释放格列吡嗪的药物递送系统
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
GB0203296D0
(en)
*
|
2002-02-12 |
2002-03-27 |
Glaxo Group Ltd |
Novel composition
|
US8323692B2
(en)
*
|
2002-02-21 |
2012-12-04 |
Valeant International Bermuda |
Controlled release dosage forms
|
CN100553625C
(zh)
|
2002-04-09 |
2009-10-28 |
弗拉梅技术公司 |
活性成分微囊的口服混悬液
|
WO2003084517A2
(fr)
|
2002-04-09 |
2003-10-16 |
Flamel Technologies |
Suspension orale de microcapsules d’amoxicilline
|
IL149055A0
(en)
*
|
2002-04-09 |
2002-11-10 |
Karma Pharm Ltd |
Extended release composition comprising as active compound venlafaxine hydrochloride
|
US20040052848A1
(en)
*
|
2002-05-23 |
2004-03-18 |
Xiu-Xiu Cheng |
Biguanide formulations
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
US8637512B2
(en)
*
|
2002-07-29 |
2014-01-28 |
Glaxo Group Limited |
Formulations and method of treatment
|
WO2004012715A1
(en)
|
2002-08-02 |
2004-02-12 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7785627B2
(en)
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
WO2004026241A2
(en)
|
2002-09-20 |
2004-04-01 |
Andrx Labs Llc |
Multistage formulation containing a biguanide and thiazolidindione derivatives
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
UA80991C2
(en)
|
2002-10-07 |
2007-11-26 |
|
Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
EP1572160A2
(en)
*
|
2002-11-28 |
2005-09-14 |
Themis Laboratories Private Limited |
Process for manufacturing sustained release microbeads containing venlafaxine hci
|
US20040115265A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Loutfy Benkerrour |
Multilayered tablet containing pravastatin and aspirin and method
|
CA2453013C
(en)
|
2002-12-13 |
2011-02-15 |
Gary W. Cleary |
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
|
DE10260921A1
(de)
*
|
2002-12-20 |
2004-07-01 |
Röhm GmbH & Co. KG |
Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln
|
TWI355276B
(en)
*
|
2003-01-14 |
2012-01-01 |
Akira Tsuji |
Gastrointestinal absorption enhancer mediated by p
|
KR100712356B1
(ko)
*
|
2003-01-23 |
2007-05-02 |
(주)아모레퍼시픽 |
서방성 제제 및 그의 제조방법
|
EP1588708A4
(en)
|
2003-01-29 |
2006-03-01 |
Takeda Pharmaceutical |
METHOD FOR PRODUCING COATED PREPARATION
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
EP1648363B1
(en)
|
2003-07-03 |
2019-03-06 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
SI1648933T1
(sl)
*
|
2003-07-25 |
2010-01-29 |
Conjuchem Biotechnologies Inc |
Dolgo delujoäś inzulinski derivat in metoda zanj
|
PL196544B1
(pl)
|
2003-08-08 |
2008-01-31 |
Biovail Lab Int Srl |
Tabletka o zmodyfikowanym uwalnianiu
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
DE10359792A1
(de)
*
|
2003-12-19 |
2005-07-21 |
Bayer Technology Services Gmbh |
Mehrphasige Wirkstoffformulierung
|
EP1711197A4
(en)
*
|
2003-12-23 |
2008-11-05 |
Musc Found For Res Dev |
METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR DISORDERS
|
US20050163842A1
(en)
*
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Rosiglitazone and metformin formulations
|
EP1732513A2
(en)
*
|
2003-12-31 |
2006-12-20 |
Alpharma, Inc. |
Rosiglitazone formulations
|
EP1559419A1
(en)
*
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
|
WO2005074894A1
(en)
|
2004-01-30 |
2005-08-18 |
Corium International |
Rapidly dissolving film for delivery of an active agent
|
EP1734953A4
(en)
*
|
2004-03-02 |
2008-08-20 |
Abeille Pharmaceuticals Inc |
CO-PR PARATIONS OF KITS OF BIOACTIVE AGENTS
|
WO2005092293A1
(en)
*
|
2004-03-22 |
2005-10-06 |
Ranbaxy Laboratories Limited |
Formulations of metformin
|
WO2005099760A1
(ja)
|
2004-04-14 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
固形製剤
|
EA011423B1
(ru)
*
|
2004-04-29 |
2009-02-27 |
Колдуэлл Гейлер, Инк. |
Метадоновые композиции местного действия и способы их применения
|
CN1988884B
(zh)
*
|
2004-06-10 |
2013-01-02 |
格拉特气体技术公司 |
控制释放基质的药物剂型组成
|
US20050285732A1
(en)
*
|
2004-06-25 |
2005-12-29 |
Sengupta Uttam K |
Radio frequency identification based system to track consumption of medication
|
US20060024368A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Reza Fassihi |
Compressed composite delivery system for release-rate modulation of bioactives
|
CN103497713B
(zh)
|
2004-08-05 |
2018-07-17 |
考里安国际公司 |
粘合剂组合物
|
US20060088594A1
(en)
*
|
2004-10-08 |
2006-04-27 |
Pilgaonkar Pratibha S |
Highly compressible controlled delivery compositions of metformin
|
JP2008528443A
(ja)
*
|
2004-10-29 |
2008-07-31 |
アドヒーシブズ・リサーチ・インコーポレイテッド |
セキュリティ・アイデンティフィケーションのための微視的なタグ付けシステム
|
US8012374B2
(en)
*
|
2004-11-04 |
2011-09-06 |
The University Of Cincinnati |
Slow-release inhibitor for corrosion control of metals
|
KR100760430B1
(ko)
*
|
2004-12-31 |
2007-10-04 |
한미약품 주식회사 |
당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
|
US20060222709A1
(en)
*
|
2005-03-18 |
2006-10-05 |
Agi Therapeutics Research Ltd. |
Metformin methods and formulations for treating chronic constipation
|
AP2244A
(en)
*
|
2005-04-26 |
2011-06-24 |
Caldwell Galer Inc |
Topical methadone compositions and methods for using the same.
|
WO2006123213A1
(en)
*
|
2005-05-18 |
2006-11-23 |
Ranbaxy Laboratories Limited |
Modified release formulations of gliclazide
|
US20060275249A1
(en)
*
|
2005-06-03 |
2006-12-07 |
Jones Michael R |
Co-therapy for diabetic conditions
|
JPWO2007010847A1
(ja)
*
|
2005-07-15 |
2009-01-29 |
キッセイ薬品工業株式会社 |
徐放製剤
|
DE602005007205D1
(de)
*
|
2005-07-19 |
2008-07-10 |
Ethypharm Sa |
Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
|
US20070077305A1
(en)
*
|
2005-10-03 |
2007-04-05 |
Le Tien C |
Biocompatible polymeric matrix and preparation thereof
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
EP1991210A1
(en)
*
|
2006-02-15 |
2008-11-19 |
Intec Pharma Ltd. |
A gastro-retentive system for the delivery of macromolecules
|
CA2648495C
(en)
|
2006-04-26 |
2016-07-05 |
Alphapharm Pty Ltd |
Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
|
AU2013202441B2
(en)
*
|
2006-04-26 |
2016-02-25 |
Alphapharm Pty Ltd |
Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
|
WO2007133750A2
(en)
*
|
2006-05-12 |
2007-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Encapsulated nanoparticles for drug delivery
|
CZ300698B6
(cs)
*
|
2006-06-16 |
2009-07-22 |
Zentiva, A. S. |
Tableta s obsahem metforminu
|
WO2008003093A2
(en)
*
|
2006-06-29 |
2008-01-03 |
Questcor Pharmaceuticals, Inc. |
Pharmaceutical compositions and related methods of treatment
|
KR100791844B1
(ko)
*
|
2006-06-30 |
2008-01-07 |
주식회사유한양행 |
메트포르민 또는 그의 염을 함유하는 서방성 제제 및 그의제조방법
|
ES2618500T3
(es)
*
|
2006-10-20 |
2017-06-21 |
Neurendo Pharma, Llc |
Método para restaurar el efecto incretina
|
CN105152983A
(zh)
|
2007-01-29 |
2015-12-16 |
韩诺生物制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
US20070172525A1
(en)
*
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
US20080064701A1
(en)
*
|
2007-04-24 |
2008-03-13 |
Ramesh Sesha |
Anti-diabetic combinations
|
KR101381999B1
(ko)
*
|
2007-07-06 |
2014-04-14 |
동아에스티 주식회사 |
위염 치료제의 효력을 극대화시키기 위한 가용화 위체류시스템 매트릭스 제제
|
US9024009B2
(en)
*
|
2007-09-10 |
2015-05-05 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
JP5292404B2
(ja)
*
|
2007-09-21 |
2013-09-18 |
ハンオル バイオファーマ カンパニー,リミテッド |
N,n−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
|
US8707964B2
(en)
*
|
2007-10-31 |
2014-04-29 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8789536B2
(en)
|
2007-10-17 |
2014-07-29 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8303573B2
(en)
|
2007-10-17 |
2012-11-06 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8808276B2
(en)
*
|
2007-10-23 |
2014-08-19 |
The Invention Science Fund I, Llc |
Adaptive dispensation in a digestive tract
|
US8333754B2
(en)
*
|
2007-10-31 |
2012-12-18 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8808271B2
(en)
*
|
2007-10-31 |
2014-08-19 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8109920B2
(en)
*
|
2007-10-31 |
2012-02-07 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US20100286200A1
(en)
*
|
2008-01-16 |
2010-11-11 |
Janssen Pharmaceutica Nv |
Combination of metformin and an mtp inhibitor
|
EP2249643A4
(en)
*
|
2008-02-05 |
2013-10-09 |
Merck Sharp & Dohme |
PHARMACEUTICAL COMPOSITIONS OF A METFORMIN AND DIPEPTIDYL PEPTIDASE-IV INHIBITOR ASSOCIATION
|
EP2259676A4
(en)
*
|
2008-03-04 |
2011-03-16 |
Merck Sharp & Dohme |
PHARMACEUTICAL COMPOSITIONS OF A COMBINATION OF METFORMIN AND A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
|
US8551524B2
(en)
*
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
FR2928836B1
(fr)
*
|
2008-03-21 |
2011-08-26 |
Servier Lab |
Forme galenique secable permettant une liberation modifiee du principe actif
|
CA2638240C
(en)
*
|
2008-08-29 |
2010-02-02 |
Alexander Macgregor |
Method of treating dysglycemia and glucose excursions
|
WO2010026467A2
(en)
|
2008-09-04 |
2010-03-11 |
Torrent Pharmaceuticals Ltd. |
Controlled release dosage form of high solubility active ingredient
|
US20100068256A1
(en)
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable medicament release-substance
|
US20100069887A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Multiple chamber ex vivo adjustable-release final dosage form
|
US9056850B2
(en)
*
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
EP2181705A1
(en)
|
2008-10-31 |
2010-05-05 |
Disphar International B.V. |
Sustained-release formulation of gliclazide
|
AU2010204986B2
(en)
|
2009-01-14 |
2016-06-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
WO2010100657A2
(en)
*
|
2009-03-04 |
2010-09-10 |
Fdc Limited |
A novel oral controlled release dosage forms for water soluble drugs
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
DK2451797T3
(da)
|
2009-07-10 |
2013-06-24 |
Janssen Pharmaceutica Nv |
Fremgangsmåde til krystallisation for 1-(b-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-fluorphenyl)-2- thienylmethyl]benzen
|
WO2011008054A2
(ko)
*
|
2009-07-17 |
2011-01-20 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 부틸산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제
|
KR20110007984A
(ko)
*
|
2009-07-17 |
2011-01-25 |
한올바이오파마주식회사 |
N,n―디메틸 이미도디카르본이미딕 디아미드의 프로피온산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제
|
SG10201500258WA
(en)
*
|
2009-10-14 |
2015-03-30 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt2
|
RU2564901C2
(ru)
*
|
2009-11-13 |
2015-10-10 |
Бристол-Майерс Сквибб Кампани |
Композиции метформина с уменьшенной массой
|
JP5775522B2
(ja)
|
2009-11-13 |
2015-09-09 |
アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag |
二層錠製剤
|
WO2011061616A2
(en)
*
|
2009-11-23 |
2011-05-26 |
Micro Labs Limited |
Extended release compositions containing tolterodine and process for preparing the same
|
US8581001B2
(en)
|
2010-04-16 |
2013-11-12 |
Codman & Shurtleff |
Metformin-cysteine prodrug
|
KR101931209B1
(ko)
|
2010-05-11 |
2018-12-20 |
얀센 파마슈티카 엔.브이. |
Sglt의 억제제로서 1-(베타-d-글루코피라노실)-2-티에닐-메틸벤젠 유도체를 포함하는 약학 제형
|
WO2011159824A1
(en)
|
2010-06-16 |
2011-12-22 |
Allergan, Inc. |
Composition and method for treating overactive bladder
|
CA2804506C
(en)
*
|
2010-07-06 |
2018-08-21 |
Janssen Pharmaceutica Nv |
Formulation for co-therapy treatment of diabetes
|
MX342120B
(es)
|
2010-07-09 |
2016-09-14 |
William Owen Wilkison |
Combinación de sistema de liberación prolongada/inmediata para productos farmacéuticos de vida media corta como el remogliflozin.
|
WO2012028934A1
(en)
*
|
2010-09-01 |
2012-03-08 |
Lupin Limited |
Pharmaceutical composition comprising metformin and pioglitazone
|
US11974971B2
(en)
|
2011-01-07 |
2024-05-07 |
Anji Pharmaceuticals Inc. |
Compositions and methods for treating metabolic disorders
|
RS61153B1
(sr)
*
|
2011-01-07 |
2020-12-31 |
Anji Pharma Us Llc |
Ligand hemosenzornog receptora-osnovne terapije
|
US11759441B2
(en)
|
2011-01-07 |
2023-09-19 |
Anji Pharmaceuticals Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
US9480663B2
(en)
|
2011-01-07 |
2016-11-01 |
Elcelyx Therapeutics, Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US9211263B2
(en)
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|
US9572784B2
(en)
|
2011-01-07 |
2017-02-21 |
Elcelyx Therapeutics, Inc. |
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
|
UY33937A
(es)
|
2011-03-07 |
2012-09-28 |
Boehringer Ingelheim Int |
Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
|
JP5973551B2
(ja)
|
2011-04-13 |
2016-08-23 |
ヤンセン ファーマシューティカ エヌ.ベー. |
Sglt2の阻害物質として有用な化合物の調製プロセス
|
US9035044B2
(en)
|
2011-05-09 |
2015-05-19 |
Janssen Pharmaceutica Nv |
L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
|
US8658631B1
(en)
|
2011-05-17 |
2014-02-25 |
Mallinckrodt Llc |
Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US20140161880A1
(en)
*
|
2011-07-26 |
2014-06-12 |
Yuhan Corporation |
Sustained release tablet comprising pregabalin through two-phase release-controlling system
|
KR102231554B1
(ko)
|
2012-01-06 |
2021-03-23 |
앤지 파마 유에스 엘엘씨 |
대사 장애를 치료하는 조성물 및 방법
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2638898A1
(en)
|
2012-03-16 |
2013-09-18 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Metformin and Pioglitazone Formulation with Different Release Profiles
|
DE102012102414A1
(de)
*
|
2012-03-21 |
2013-10-10 |
Michael Dittgen |
Pharmazeutische Zusammensetzung für die einmal tägliche Anwendung antidiabetischer Arzneimittel wie Metformin mit Zwei-Puls-Freisetzung
|
WO2014014427A1
(en)
|
2012-07-16 |
2014-01-23 |
Mahmut Bilgic |
Modified release pharmaceutical tablet formulations
|
WO2014105218A2
(en)
*
|
2012-07-31 |
2014-07-03 |
Hercules Incorporated |
Stabilized multiphase aqueous compositions
|
WO2014154643A1
(en)
*
|
2013-03-25 |
2014-10-02 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Extended release formulations of metformin
|
US20150374688A1
(en)
|
2013-03-26 |
2015-12-31 |
Wockhardt Limited |
Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof.
|
EP2996680A1
(en)
|
2013-03-28 |
2016-03-23 |
Wockhardt Limited |
Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
|
JP5775970B2
(ja)
*
|
2013-05-31 |
2015-09-09 |
久光製薬株式会社 |
口腔貼付剤
|
KR101597004B1
(ko)
|
2013-07-25 |
2016-02-23 |
씨제이헬스케어 주식회사 |
서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
|
EP3137062A4
(en)
*
|
2014-04-29 |
2018-01-03 |
Matripharm Inc. |
Monolithic tablets based on carboxyl polymeric complexes for controlled drug release
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
US10034871B2
(en)
|
2014-11-07 |
2018-07-31 |
Regents Of The University Of Minnesota |
Salts and compositions useful for treating disease
|
MA39929A
(fr)
|
2014-11-27 |
2016-06-01 |
Arven Ilac Sanayi Ve Ticaret As |
Comprimé multicouche comprenant de la metformine et du pioglitazone
|
US20170071970A1
(en)
|
2015-09-15 |
2017-03-16 |
Janssen Pharmaceutica Nv |
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
|
CA3001337C
(en)
|
2015-10-09 |
2023-12-12 |
Reckitt Benckiser Llc |
Pharmaceutical formulation
|
EP3429573A4
(en)
|
2016-03-17 |
2019-10-30 |
Thiogenesis Therapeutics, Inc. |
COMPOSITIONS FOR THE CONTROLLED RELEASE OF CYSTEAMINE AND FOR SYSTEMIC TREATMENT OF CYSTEAMIN SENSITIVE DISEASES
|
TR201620309A2
(tr)
|
2016-12-30 |
2018-07-23 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇
|
CR20190577A
(es)
|
2017-07-17 |
2020-01-29 |
Lilly Co Eli |
Composiciones farmacéuticas
|
WO2019018158A1
(en)
|
2017-07-17 |
2019-01-24 |
Eli Lilly And Company |
PHARMACEUTICAL COMPOSITIONS
|
WO2019027372A1
(en)
*
|
2017-08-02 |
2019-02-07 |
Nanyang Technological University |
FLOATABLE PHARMACEUTICAL MICROCAPSULE COMPOSITION
|
JP7208982B2
(ja)
|
2017-09-20 |
2023-01-19 |
チオジェネシス セラピューティクス, インコーポレイテッド |
システアミン感受性障害の治療方法
|
CN114191307A
(zh)
|
2020-09-17 |
2022-03-18 |
上海汉都医药科技有限公司 |
一种口腔滞留装置及其制备方法
|
JP7125791B2
(ja)
|
2018-05-23 |
2022-08-25 |
シャンハイ ダブリュディー ファーマシューティカル カンパニー,リミティド |
活性薬物成分の放出制御システムおよびその製造方法
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
KR20210031910A
(ko)
|
2018-06-19 |
2021-03-23 |
싱가포르국립대학교 |
다양한 적응증에 대한 향상된 생체 이용률을 위한 5-하이드록시트립토판의 제형
|
CN110354090B
(zh)
*
|
2019-07-29 |
2021-10-01 |
石药集团欧意药业有限公司 |
一种盐酸二甲双胍缓释片及其制备方法
|
WO2021042278A1
(zh)
*
|
2019-09-04 |
2021-03-11 |
鲁南贝特制药有限公司 |
一种阿昔莫司多单元缓释微丸片及其制备方法
|
EP3932974B1
(en)
*
|
2020-06-30 |
2023-02-22 |
Fujifilm Business Innovation Corp. |
Biodegradable resin particle
|
CN116801868A
(zh)
|
2021-07-30 |
2023-09-22 |
埃维西亚治疗公司 |
5-羟色氨酸胃滞留剂型
|
CN113662940B
(zh)
*
|
2021-09-02 |
2023-03-24 |
福州大学 |
一种盐酸二甲双胍和TGF-β抑制剂自组装的纳米材料
|
WO2023064598A1
(en)
|
2021-10-14 |
2023-04-20 |
Evecxia Therapeutics, Inc. |
A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes
|
IT202100031691A1
(it)
|
2021-12-17 |
2023-06-17 |
I B N Savio S R L |
Processo produttivo di compresse a rilascio sostenuto di metformina
|
CN114404376A
(zh)
*
|
2022-03-16 |
2022-04-29 |
成都恒瑞制药有限公司 |
一种盐酸二甲双胍缓释片剂及其制备方法
|